Both in Biotechnology
Amgen vs Gilead Sciences
Over the past year AMGN returned +52.6% and GILD returned +35.2%; their daily moves had a correlation of 0.47.
AMGN +52.6% GILD +35.2%Growth of $1, one year, split-adjusted
| Metric | AMGN | GILD |
|---|---|---|
| Price | $418.13 | $152.21 |
| Market cap | $226.05B | $188.73B |
| Today | +0.85% | +0.85% |
| 1 month | −4.3% | +2.3% |
| 6 months | +19.9% | +13.4% |
| Year to date | +27.7% | +24.0% |
| 1 year | +54.2% | +37.1% |
| Revenue growth (YoY) | +9.5% | +10.2% |
| Gross margin | 72.0% | 79.8% |
| Net margin | 23.6% | −134.5% |
| P/E (TTM) | 25.9× | — |
| Price / sales | 5.9× | 6.2× |
| Net cash | -$43.31B | -$23.07B |
| Dividend yield | 2.41% | 2.15% |
| Volatility (60d) | 34.0% | 27.0% |
| Short % of float | 2.6% | 1.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).